Intensive Intraoperative Insulin Therapy versus Conventional Glucose Management during Cardiac Surgery

Abstract

Intensive insulin therapy during cardiac surgery does not reduce perioperative death or morbidity. The increased incidence of death and stroke in the intensive treatment group raises concern about routine implementation of this intervention.